Livongo Health (NASDAQ:LVGO) Research Coverage Started at Morgan Stanley

Morgan Stanley began coverage on shares of Livongo Health (NASDAQ:LVGO) in a research note released on Monday, BenzingaRatingsTable reports. The firm issued an equal weight rating and a $42.00 price target on the stock.

Several other brokerages have also recently issued reports on LVGO. Needham & Company LLC assumed coverage on Livongo Health in a research report on Monday. They set a buy rating and a $42.00 price target on the stock. KeyCorp assumed coverage on Livongo Health in a research report on Monday. They set an overweight rating and a $46.00 price target on the stock. Canaccord Genuity assumed coverage on Livongo Health in a research report on Monday. They set a buy rating and a $46.00 price target on the stock. Goldman Sachs Group assumed coverage on Livongo Health in a research report on Monday. They set a buy rating and a $43.00 price target on the stock. Finally, Leerink Swann assumed coverage on Livongo Health in a research report on Monday. They set an outperform rating and a $50.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Livongo Health presently has an average rating of Buy and an average price target of $44.20.

Shares of LVGO stock opened at $35.42 on Monday. Livongo Health has a 1 year low of $31.60 and a 1 year high of $45.68.

In related news, major shareholder Ab (Publ) Kinnevik bought 3,141,795 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were acquired at an average cost of $28.00 per share, for a total transaction of $87,970,260.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Hemant Taneja bought 2,678,571 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was bought at an average price of $28.00 per share, for a total transaction of $74,999,988.00. The disclosure for this purchase can be found here.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Featured Article: Marijuana Stocks Future Looks Bright

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.